pd 173074 has been researched along with Syndrome in 1 studies
Syndrome: A characteristic symptom complex.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gudernova, I | 1 |
Vesela, I | 1 |
Balek, L | 1 |
Buchtova, M | 1 |
Dosedelova, H | 1 |
Kunova, M | 1 |
Pivnicka, J | 1 |
Jelinkova, I | 1 |
Roubalova, L | 1 |
Kozubik, A | 1 |
Krejci, P | 1 |
1 other study available for pd 173074 and Syndrome
Article | Year |
---|---|
Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short-stature syndromes.
Topics: Achondroplasia; Animals; Benzamides; Cartilage; Catalysis; Cells, Cultured; Chick Embryo; Chondrocyt | 2016 |